ID | 1298 |
Name of the vaccine | Tetrabik |
Microbe | Bacteria |
Disease name | Tetanus (Lock Jaw) |
Name of bacteria | Clostridium tetani |
Type of vaccine | Combination |
Nucleic acid content | DNA |
Age | 6 to 11 weeks |
Description of the vaccine | DTP-IPV vaccine used as part of the Japanese vaccination schedule. |
Name of the manufacturer | Merck Sharp & Dohme Corp. |
Name of the manufacturing country | NA |
Year of manufacture | 2014 |
Clinical Phase status | Clinical - Phase 4 |
Bacterial strain | Gram-positive bacteria. |
Efficacy | NA |
Vaccine formulation | NA |
Dosage | Dose of 0.5 mL administered thrice. |
Mechanism of action | NA |
Route of administration | Subcutaneous |
Indications | NA |
Export | NA |
Approval | NA |
Adjuvant | NA |
Repurposing | For diphtheria, tetanus, pertussis and inactivated poliovirus. |
Side effects of vaccine | NA |
Post vaccination | NA |
Dose type | Combination doses |
Interspecies transfer | NA |
PubMed identifier | NA |
Clinical trial number | NCT01926015 |
Reference | NA |
Other name | NA |
Additional Links | NA
|